Whole Blood Coagulation Time
"Whole Blood Coagulation Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The time required by whole blood to produce a visible clot.
|Whole Blood Coagulation Time
- Whole Blood Coagulation Time
- Blood Coagulation Time, Whole
- Coagulation Time, Whole Blood
- Activated Coagulation Time, Whole Blood
Below are MeSH descriptors whose meaning is more general than "Whole Blood Coagulation Time".
Below are MeSH descriptors whose meaning is more specific than "Whole Blood Coagulation Time".
This graph shows the total number of publications written about "Whole Blood Coagulation Time" by people in this website by year, and whether "Whole Blood Coagulation Time" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Whole Blood Coagulation Time" by people in Profiles.
Groves DS, Welsby IJ, Naik BI, Tanaka K, Hauck JN, Greenberg CS, Winegar DA, Viola F. Multicenter Evaluation of the Quantra QPlus System in Adult Patients Undergoing Major Surgical Procedures. Anesth Analg. 2020 04; 130(4):899-909.
DeNino WF, Carter CB, Sievert A, Goss A, Toole JM, Mukherjee R, Uber WE. The effect of ultrafiltration with cardiopulmonary bypass on the removal of dabigatran from the circulation of adult pigs. Perfusion. 2016 Jul; 31(5):424-30.
Thompson K, Alred J, Deyo A, Sievert AN, Sistino JJ. Effect of New Heparin Potency on Activated Clotting Time during Pediatric Cardiac Surgery: A Retrospective Chart Review. J Extra Corpor Technol. 2014 Sep; 46(3):224-8.
Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013 Jun; 116(6):1210-22.
Tolleson TR, O'Shea JC, Bittl JA, Hillegass WB, Williams KA, Levine G, Harrington RA, Tcheng JE. Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial. J Am Coll Cardiol. 2003 Feb 05; 41(3):386-93.
Gerhardt MA, Greenberg CS, Slaughter TF, Stafford Smith M. Factor XII deficiency and cardiopulmonary bypass: use of a novel modification of the activated clotting time to monitor anticoagulation. Anesthesiology. 1997 Oct; 87(4):990-2.
Peverini RL, Sale M, Rhine WD, Fagan LM, Lenert LA. Anticoagulation therapy advisor: a decision-support system for heparin therapy during ECMO. Proc Annu Symp Comput Appl Med Care. 1992; 567-71.